News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

JMAR Technologies (JMAR) Forms Unit for Radiological/Nuclear Detection, Hires Leading Systems Engineer



8/22/2008 9:19:51 AM

Company’s New Spectral Labs Division, Led by James Winso, Fills Out JMAR Suite of Threat-Detection Technologies

SAN DIEGO--(BUSINESS WIRE)--JMAR Technologies, Inc. (OTCBB: JMAR) a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that it has formed a new subsidiary, Spectral Labs, Inc. to design and develop equipment to detect, locate and identify radiological/nuclear threats with minimum intrusion.

Spectral Labs is led by James H. Winso, President of the subsidiary, who will also serve as Vice President of Business Development for JMAR CBRNE products.

Mr. Winso brings with him more than three decades of experience developing nuclear detection and measurement systems. Prior to founding Spectral Labs, Winso was with Science Applications International Corp. (SAIC) from 1986 until 2007, serving as a Senior Vice President responsible for program and division management on a wide range of radiation instruments and radiographic imaging programs. Before that, he was Director of Engineering for a subsidiary of General Atomics, responsible for designing nuclear power plant safety systems and Navy radiation monitoring and safety systems.

Winso previously was employed as an electrical engineer at Westinghouse Corp., where he designed a computer controlled system for positioning and monitoring movable control elements in a Nuclear Reactor. While with Westinghouse, he graduated first in his class from the Naval Nuclear Power Engineering School at the Naval Reactor Facility, Idaho Falls, Idaho. Winso holds an M.S. in nuclear science and engineering from Carnegie Mellon University and a B.S. (with highest honors) in physics from Drexel University.

JMAR Technologies’ CEO, C. Neil Beer, Ph.D., commented, “James Winso is prominent in the industry for his expertise in developing systems for nuclear detection. Now that he and his team are part of JMAR, we have radiological detection capabilities to complement our strong portfolio of chemical, biological and explosive detection products.”

To be added to JMAR Technologies’ investor lists, please contact Haris Tajyar at htajyar@irintl.com or at 818-382-9702.

About JMAR

JMAR Technologies, Inc. (OTCBB: JMAR) is a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials. Coupled with its established expertise in building advanced laser systems, JMAR provides solutions for a broad range of military, industrial and commercial applications. The Company draws on more than twenty years of experience and thirty patents in photonics, laser and detection technologies to develop products and solutions that address some of the world’s most pressing issues such as water quality, hazard detection and homeland security. JMAR’s vision is to continue to develop innovative technologies and products that support the advancement of global health, safety, and security initiatives. For further information on JMAR Technologies, please visit www.jmar.com.

Forward Looking Statements: This news release contains certain “forward-looking statements.” Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company’s control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the uncertainty of acceptance in the market for our products and technologies or the acceptance of our customers’ products or technologies which incorporate our products and technologies, the failure of our technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets, cost and margins for JMAR’s products, current or future government regulations affecting the use of JMAR’s products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company’s Form 10-K for the year ended December 31, 2007 filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.

Contacts

Investor Relations International Haris Tajyar, Managing Partner 818-382-9702 htajyar@irintl.com or JMAR Technologies Kathi Kirchmeier, Marketing Communications Manager 858-946-6800 kkirchmeier@jmar.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES